On the occasion of World Cancer Day 2024; focus on hypertension and anti-cancer agents

IF 0.2 Q4 UROLOGY & NEPHROLOGY

Journal of Renal Injury Prevention Pub Date : 2024-01-29 DOI:10.34172/jrip.2024.32259

Parisa Tajdini, M. Foroutan

引用次数: 0

Abstract

Oncohypertension is a relatively recent concept that refers to the development of elevated blood pressure in patients with cancer, which is driven by the tumor itself. This review article aims to provide an overview of oncohypertension, including its pathophysiology, clinical implications, diagnostic approaches, and management strategies. The study discusses the association between oncological disorders and hypertension, highlighting the underlying mechanisms responsible for the development of oncohypertension. Furthermore, various diagnostic methods, including imaging techniques and laboratory tests, are discussed in detail. Finally, treatment options for oncohypertension, including both pharmacological and non-pharmacological approaches, are thoroughly reviewed to optimize blood pressure control and improve patient outcomes.

查看原文本刊更多论文

2024 年世界癌症日；关注高血压和抗癌药物

肿瘤性高血压是一个相对较新的概念，是指肿瘤患者因肿瘤本身的原因导致血压升高。这篇综述文章旨在概述肿瘤性高血压，包括其病理生理学、临床意义、诊断方法和管理策略。研究讨论了肿瘤疾病与高血压之间的关联，强调了导致肿瘤性高血压发生的潜在机制。此外，还详细讨论了各种诊断方法，包括成像技术和实验室检测。最后，深入探讨了肿瘤性高血压的治疗方案，包括药物和非药物治疗方法，以优化血压控制和改善患者预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Renal Injury Prevention UROLOGY & NEPHROLOGY-

CiteScore

1.60

自引率

0.00%

发文量

期刊介绍： The Journal of Renal Injury Prevention (JRIP) is a quarterly peer-reviewed international journal devoted to the promotion of early diagnosis and prevention of renal diseases. It publishes in March, June, September and December of each year. It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views and renal biopsy teaching point. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy. A further aim of this journal is to emphasize and strengthen the link between renal pathologists/nephropathologists and nephrologists. In addition, JRIP welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology. Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted.